University of Hawaii at Manoa Homepage

Past Events and Seminar Series


Click on the links below to view past events and seminar series by year.

2017

2016

2015

2014

2013

2012

Past Events and Seminar Series

2017

View by year:
2017 | 2016 | 2015 | 2014 | 2013 | 2012

Hua Zhao, PhD

  • Date: July 17, 2017
  • Title: Molecular Epidemiology of Cancer and Obesity in the Mexican American Mano A Mano Cohort"
  • UT MD Anderson Cancer Center
Melissa A. Merritt, PhD

  • Date: July 11, 2017
  • Title: Ovarian and Endometrial Cancer Epidemiology: New Insights in Survivorship Research
  • UH Cancer Center
Susan M. Schembre, PhD, RD

  • Date: June 19, 2017
  • Title: Next-gen mHealth: Integrating Body Sensors With Smart Technology to Motivate Health Behavior Change
  • UT MD Anderson Cancer Center
Sora Park Tanjasiri, DrPH, MPH

  • Date: June 13, 2017
  • Title: Creating a Cancer Disparities Network for Pacific Islanders: Lessons Learned and Future Directions
  • California State University, Fullerton
John A Shepherd, PhD, CCD

  • Date: May 10, 2017
  • Title: Pushing the radiomic limits of mammography for breast cancer risk, lesion typing, and masking
  • UCSF School of Medicine
John B. Cologne, Ph.D.

  • Date: May 9, 2017
  • Title: Complete Causal Modeling of Observational Data on Liver Cancer
  • Department of Statistics Hiroshima, Japan
Wendy Cozen, D.O., M.P.H.

  • Date: April 17, 2017
  • Title: From Cis to Trans: Molecular Epidemiology in the Precision Medicine Era
  • University of Southern California
Deborah Boggs Bookwalter, Sc.D., PhD

  • Date: April 10, 2017
  • Title: Breast Cancer Risk Prediction for African American Woman
  • Naval Health Research Center
Ming-Yu Ngai, PhD

  • Date: January 17, 2017
  • Title: Development of Novel Chemical Tools for Accessing Unexplored Chemical Spaces
  • Stony Brook University

20BY25 One Step Closer

What is 20BY25?

Overall Goal – Ensure that the people of Hawai‘i receive the highest quality of cancer care

Clinical Trials Facts

  1. Clinical trials provide the highest level of quality of care for patients with cancer1
  2. The mortality rate from cancer is falling, in large part due to cancer research that has, through clinical trials, led to new and better methods of cancer prevention, detection and treatment.
  3. Children with cancer are enrolled onto clinical trials at a rate of 70-75% across the US.  A clinical trial is the standard of care.
  4. Only 2-3% of adults with cancer in the US enroll onto clinical trials.

Why do clinical trials provide the highest quality of care for cancer patients?

  1. Closer supervision and monitoring than standard care
  2. Patients always receive equal to or better than the standard of care
  3. Access to novel drugs, or new drug combinations, that may improve the response to treatment, increase the chance of cure, and prolong survival

Today’s “standard” treatment was a
clinical trial 5-10 years ago

Today’s clinical trial will be
standard care 5-10 years from now

Initiative focused on:

    • Community education about cancer clinical trials
    • Engagement and training of oncology providers
    • Encouraging enrollment to cancer clinical trials

Long Term Goal

20% of all Hawaii cancer cases each year enrolled to cancer clinical trials by 2025.

    • There are ~6500 new cancer cases each year in Hawaii
    • The goal is to enroll 1300 patients per year onto a cancer clinical trial
    • At least 1/2 of these enrollments should be to treatment-based trials.  Others may be to cancer prevention, supportive care, diagnostic and cancer healthcare delivery trials.

Hawaii will be the ONLY state in the US to achieve this high proportion of enrollment to clinical trials statewide.

The University of Hawaii Cancer Center, which already provides a clinical trial infrastructure for over 2/3 of cancer patients in the State, is uniquely positioned to lead this initiative.

Key Activities of the Initiative:

  • Educate the public about the value of cancer clinical trials
  • Establish a training and certification program for providers (physicians, nurses), clinical research staff and lay advocates/educators
  • Augment the clinical trials infrastructure to facilitate community-based clinical trials participation and enrollment on Oahu
  • Establish partners on neighbor islands to extend access to clinical trials
  • Coordinate cancer clinical trials across various healthcare systems in Hawai‘i

 

LET’S TAKE ONE STEP CLOSER TO CURING CANCER!

SPONSORSHIP LEVELS:

Corporate, Healthcare and Foundation Sponsorships

Individual Sponsorships


1National Comprehensive Cancer Network; American Cancer Society; National Cancer Institute



logo


This e-mail address is being protected from spambots. You need JavaScript enabled to view it.


To support 20BY25, please contact:

Todd Cullison

Associate Director of Development,
UH Cancer Center

701 Ilalo Street, 3rd Floor
Honolulu, HI 96813
Telephone:
(808) 356-5757
Fax:
(808) 586-3052

This e-mail address is being protected from spambots. You need JavaScript enabled to view it.


More Information:

American Cancer Society Clinical Trials

National Cancer Institute Clinical Trials

What are Clinical Trials?

Clinical Trials National Website

UH Cancer Center Clinical Trials Office


What are Clinical Trials

A clinical trial is a research study designed to test the safety and effectiveness of new treatments for cancer. Every cancer-fighting drug and therapy available to doctors today had to be tested in a clinical trial before it could be used routinely on patients.

University of Hawai'i Cancer Center is geared for precision. Clinical studies are designed to enhance & compliment ongoing advancements in the understanding of cancer. These efforts drive what is commonly referred to as personalized medicine. Increasingly sophisticated treatments use this information to target specific oncology targets or biomarkers. Traditionally, clinical research programs relied on a more generalized approach. Treatments were trialed for specific therapeutic areas. The potential of increasingly-targeted, precision medicine is moving beyond that approach by using a person's own biological make-up to grant access to cutting edge research, while also minimizing patient exposure to trials that do not match their biology.

Partnering for a Cure
Being diagnosed with cancer is a life-changing experience. But thanks to advances in biomedical research, cancer patients today have more reasons to hope for a positive outcome than ever before. Doctors have an arsenal of drugs, chemotherapies, radiation therapies and other treatments that can either cure or delay for many years the progression of most types of cancer.

Unfortunately, these therapies are not perfect and thus do not work for everyone. Cancer is still the second-leading cause of death in the United States, killing nearly 560,000 Americans every year. (Source: Centers for Disease Control and Prevention).

Research scientists at University of Hawai'i Cancer Center are working hard every day to find new, more effective drugs and therapies to fight cancer. But they cannot do it alone. To succeed, researchers need more people willing to volunteer for a clinical trial to determine how well these potential cancer treatments work. Today, there's a nationwide shortage of research volunteers and it is slowing progress in the fight against cancer. There are a lot of myths and misconceptions about what it's like to be part of a clinical trial. Volunteering does not make you a guinea pig; it makes you a partner in the discovery process. If you have cancer, it's a way to make an important contribution to the future of medicine that only you can make.

Smiley face
"I'm able to chase and accomplish all my dreams I had for myself because of the successful clinical trial."
University of Hawai'i Cancer Center Clinical Trial Participant
Mari, Leukemia

Contact Information

Clinical Trials Office
701 Ilalo Street, 3rd Floor
Honolulu, HI 96813
Telephone:
(808) 586-2979
Fax:
(808) 586-2984